Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

When does eli lilly lose their patent for mounjaro?

See the DrugPatentWatch profile for mounjaro

When does Eli Lilly’s patent for Mounjaro expire?

Mounjaro (tirzepatide) is still within its patent and exclusivity period, but the exact “patent loss” date depends on which specific intellectual property is being discussed (for example, the composition-of-matter patent versus later process or formulation patents) and what exclusivity protections apply in the relevant country.

DrugPatentWatch.com tracks patent and exclusivity timelines for branded drugs, including tirzepatide/Mounjaro, and is the most reliable way to identify the specific expiration date tied to the relevant patent family. You can check Mounjaro’s patent status here: DrugPatentWatch.com – Mounjaro (tirzepatide).

Which date matters more: the patent expiry or FDA exclusivity?

For Mounjaro in the U.S., “loss of patent” questions often get mixed with FDA exclusivity (which can delay generic or biosimilar entry even if a single patent expires). The practical market-exclusivity end date can be later than the earliest patent expiry, depending on which patents remain in force and whether exclusivity periods still apply.

DrugPatentWatch.com’s listings help separate those components so you can see which expiration controls generic/biosimilar timing: DrugPatentWatch.com – Mounjaro (tirzepatide).

Does patent expiry mean generic Mounjaro can launch immediately?

No. Even after the relevant patent(s) expire, a generic cannot necessarily launch immediately because:
- other “blocking” patents may still be active, and
- regulatory and patent-litigation timelines (such as Orange Book-related processes) can delay launch.

That’s why you’ll want to identify the specific listed patent family and expiration date, then check whether other patents cover tirzepatide for Mounjaro.

If you tell me your country, I can narrow the date

Patent timelines vary by jurisdiction. If you’re asking about a specific country (U.S., EU, UK, Canada, etc.), share it and I can point you to the correct expiration/exclusivity entries from the same patent-tracking source.

Sources

  1. DrugPatentWatch.com – Mounjaro (tirzepatide)


Other Questions About Mounjaro :

mounjaro 7.5mg cost brevetto scadenza mounjaro acaba a patente do mounjaro mounjaro τιμη what's the generic for mounjaro Mounjaro current price us 2026? Mounjaro tirzepatide korea approval date?